Skip to main content

[New post] Dr. Revati Shreeniwas Joins ImmunoMet Therapeutics as Chief Medical Officer

Daniel Webster posted: " HOUSTON--(BUSINESS WIRE)--ImmunoMet Therapeutics, Inc., a clinical stage biotechnology company targeting metabolism to develop novel anti-fibrotic and anti-cancer therapies, today announced that Dr. Revati Shreeniwas has joined the company as Chi"

Comments

Popular posts from this blog

Melinda Gates reportedly consulted with divorce lawyers since 2019

[New post] STUNNING: Magnetized Threads Weave Spectacular Galactic Tapestry

Top No-Code Tools to Automate Your Approval Process